Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (171-180 of 317) with videos related to

Pageof 32
Sort By:
Cancer|August 1, 1972
Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinomaH H Hansen, F M Muggia, R Andrews, et al.
The Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.
JAMA|October 11, 1976
Activity of daunomycin in solid tumorsD D Von Hoff, M Rozencweig, M Slavik, et al.
Acta Cytologica|July 1, 1977
A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspiratesF T Elequin, F M Muggia, N A Ghossein, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
BRCA1 germline mutation presenting as an adenocarcinoma of unknown primaryP Klein, G Prolla, R Wallach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Maintenance chemotherapy in advanced ovarian cancerM S Piver, F M Muggia, M F Brady, et al.
Annals of Internal Medicine|December 1, 1970
Hypercalcemia in cancerJ Horton, K B Olsen, F M Muggia, et al.
The New England Journal of Medicine|December 14, 1978
Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?M Rozencweig, M Zelen, D D Von Hoff, et al.
Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.
Cancer Treatment Reports|October 1, 1977
Time relationship between last dose of daunorubicin and congestive heart failureD D Von Hoff, M Layard, M Rozencweig, et al.
Pageof 32

Showing results (171-180 of 317) with videos related to

Sort By:
Pageof 32
Cancer|August 1, 1972
Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinomaH H Hansen, F M Muggia, R Andrews, et al.
The Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.
JAMA|October 11, 1976
Activity of daunomycin in solid tumorsD D Von Hoff, M Rozencweig, M Slavik, et al.
Acta Cytologica|July 1, 1977
A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspiratesF T Elequin, F M Muggia, N A Ghossein, et al.
Cancer Journal (Sudbury, Mass.)|July 6, 2000
BRCA1 germline mutation presenting as an adenocarcinoma of unknown primaryP Klein, G Prolla, R Wallach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Maintenance chemotherapy in advanced ovarian cancerM S Piver, F M Muggia, M F Brady, et al.
Annals of Internal Medicine|December 1, 1970
Hypercalcemia in cancerJ Horton, K B Olsen, F M Muggia, et al.
The New England Journal of Medicine|December 14, 1978
Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?M Rozencweig, M Zelen, D D Von Hoff, et al.
Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.
Cancer Treatment Reports|October 1, 1977
Time relationship between last dose of daunorubicin and congestive heart failureD D Von Hoff, M Layard, M Rozencweig, et al.
Pageof 32